Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

H.R. 6 · 118th Congress

Reserved for the Speaker.

Died in committeeText pending Introduced Jan 3, 2023 · Latest action Jan 6, 2023

FollowRead the text
How far it has goneStopped at 1 of 6 · Died in committee
  1. IntroducedDied Jan 3, 2025 Stopped here
  2. CommitteeNot yet Not reached yet
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

1 organization · 1 filing · Q1 2023–Q4 2024

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Alkermes, Inc. 1 of 8 quarters
    “Prescription drug pricing. H.R.6 - SUPPORT for Patients and Communities Act. Awareness of outcomes data and the need for training on all medication assisted treatment. H.R.7667/S.4348 - Prescription Drug User Fee Agreement Reauthorization. Implementation of Inflation Reduction Act of 2022.”

    Q1 2023 filing · $3.6M lobbying spend in 2023, all issues

Organizations that named H.R. 6 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

2 actions · newest first
  1. Jan 6, 2023Introduced in House
  2. Jan 3, 2023Introduced in House